Rotigotine protects against oxidized low-density lipoprotein(ox-LDL)-induced damages in human umbilical vein endothelial cells(HUVECs)

References

• Khan T. Cardiovascular diseases. World Health Organisation-Health-topics
   Google Scholar
• Arteriosclerosis/atherosclerosis. Mayo Clin. 2021.
   Google Scholar
• Atherosclerosis.National Heart, Lung, and Blood Institute
   Google Scholar
• Ross R, Dodet B. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(5):S419–S420.
   PubMed Web of Science ®Google Scholar
• Tang Z, Jiang L, Peng J, et al. PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κΒactivation in THP-1-derived macrophages. Int J Mol Med. 2012;30(4):931–938.
   PubMed Web of Science ®Google Scholar
• Nayler W. Atherosclerosis and endothelial damage: a brief overview. Cardiovasc Drugs Ther. 1995;9(S1):25–30.
   Google Scholar
• Gimbrone M Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016 Feb 19;118(4):620–636.
   PubMed Web of Science ®Google Scholar
• Howe K, Fish J. Transforming endothelial cells in atherosclerosis. Nat Metab. 2019;1(9):856–857.
   PubMedGoogle Scholar
• Li J, Liang X, Wang Y, et al. Investigation of highly expressed PCSK9 in atherosclerotic plaques and oxLDL-induced endothelial cell apoptosis. Mol Med Rep. 2017;16(2):1817–1825.
   PubMed Web of Science ®Google Scholar
• Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983;24(8):1070–1076.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(12):2311–2316.
   PubMed Web of Science ®Google Scholar
• Karimi S, Dadvar M, Modarress H, et al. Kinetic modeling of lowdensity lipoprotein oxidation in arterial wall and its application in atherosclerotic lesions prediction. Chem Phys Lipids. 2013;175-176:1–8.
   PubMed Web of Science ®Google Scholar
• Lina XL, Xiaob LL, Tang ZH, et al. Role of PCSK9 in lipid metabolism and atherosclerosis. Biomed Pharmacother. 2018;104:36–44.
   PubMed Web of Science ®Google Scholar
• Miserez A, Muller P, Barella L, et al. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis. 2002;164(1):15–26.
   PubMed Web of Science ®Google Scholar
• Madison B. Srebp2: a master regulator of sterol and fatty acid synthesis. J Lipid Res. 2016 Mar;57(3):333–335.
   PubMed Web of Science ®Google Scholar
• Mathur K, Patney N, Kumar V, et al. Serum Cholesterol and Atherosclerosis in Man. Circulation. 1961;23(6):847–852.
   PubMed Web of Science ®Google Scholar
• Frostegard J, Ulfgren AK, Nyberg P, et al. Andersson U and Hansson GK: cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145(1):33–43.
   PubMed Web of Science ®Google Scholar
• Jovinge S, Ares MP, Kallin B, et al. Human monocytes/macrophages release TNF-alpha in response to ox-LDL. Arterioscler Thromb Vasc Biol. 1996;16(12):1573–1579.
   PubMed Web of Science ®Google Scholar
• Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol. 2010;594:57–72.
   PubMedGoogle Scholar
• Khreiss T, József L, Potempa LA. Potempa LA and Filep JG: conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 2004;109(16):2016–2022.
   PubMed Web of Science ®Google Scholar
• Kaneto H, Katakami N, Matsuhisa M, et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. 2010;2010:453892.
   PubMed Web of Science ®Google Scholar
• Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101(25):2889–2895.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang W, Liu J, et al. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway. Bioengineered. 2021;12(1):4520–4535.
   PubMed Web of Science ®Google Scholar
• Frostegard J, Nilsson J, Haegerstrand A, et al. OxidizedLow density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A. 1990;87(3):904–908. 10.1073/pnas.87.3.904.
   PubMed Web of Science ®Google Scholar
• Brand K, Eisele T, Kreusel U, et al. Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 1997;17(10):1901–1909.
   PubMed Web of Science ®Google Scholar
• Takahara N, Kashiwagi A, Nishio Y, et al. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells. Diabetologia. 1997;40(6):662–670.
   PubMed Web of Science ®Google Scholar
• Rajavashisth TB, Yamada H, Mishra NK. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor- κB. Arterioscler Thromb Vasc Biol. 1995;15(10):1591–1598.
   PubMed Web of Science ®Google Scholar
• Rotigotine. Compound Summary. PubChem CID. 59227
   Google Scholar
• Wood M, Dubois V, Scheller D, et al. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. BrJ Pharmacol. 2015;172(4):1124–1135. Life Sci 2015;124:136-43.
   PubMed Web of Science ®Google Scholar
• Chen L, Fang ZD, Wang XT, et al. G protein-coupled receptor 39 activation alleviates oxidized low-density lipoprotein-induced macrophage inflammatory response, lipid accumulation and apoptosis by inducing A20 expression. Bioengineered. 2021;12(1):4070–4080.
   PubMed Web of Science ®Google Scholar
• Wu YL, Hao RN, Lan BD, et al. The protective effects of naproxen against interleukin-1β (IL-1β)- induced damage in human umbilical vein endothelial cells (HUVECs). Bioengineered. 2021;12(1):5361–5372.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker P, Maseri A. Inflammation andatherosclerosis. Circulation. 2002;105(9):1135–1143.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yuan F, Liu P, et al. Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: casecontrol study and meta-analysis. Clin Biochem. 2013;46(9):727–732.
   PubMed Web of Science ®Google Scholar
• Wu NQ, Li JJ. PCSK9 gene mutations and low-density lipoprotein cholesterol. Clin Chim Acta. 2014;431:148–153.
   PubMed Web of Science ®Google Scholar
• Dong B, Wu M, Li H, et al. Strong induction of PCSK9 gene expression through ΗNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J Lipid Res. 2010;51(6):1486–1495.
   PubMed Web of Science ®Google Scholar
• Dubuc G, Chamberland A, Wassef H, et al. “Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia”. Arterioscler Thromb Vasc Biol. 2004;24(8):1454–1459.
   PubMed Web of Science ®Google Scholar
• Hyun J, Lee H, Kim K, et al. Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2. J Lipid Res. 2008;49(2):399–409.
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu S, Wang X, et al. MehtaJ“Cross-Talk between LOX-1 andPCSK9 in vascular tissues”. Cardiovasc Res. 2015;107(4):556–567.
   PubMed Web of Science ®Google Scholar
• Cm H, Ho SL, Jeng YM, et al. Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease. J Inflam. 2019;16:7. Article number.
   Google Scholar
• Cominacini L, Pasini A, Garbin U, et al. Oxidized low-density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275(17):12633–12638.
   PubMed Web of Science ®Google Scholar
• Vendrov A, Madamanchi N, Niu X, et al. NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J Biol Chem. 2010;285(34):26545–26557.
   PubMed Web of Science ®Google Scholar
• Xu H, Goettsch C, Xia N, et al. Differential roles of PKC alpha and PKC epsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med. 2008;44(8):1656–1667.
   PubMed Web of Science ®Google Scholar
• Li R, Chen B, Wu W, et al. Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-kappa B activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein. J Pharm Sci. 2009;110(3):362–369.
   Web of Science ®Google Scholar
• Krishnaswamy G, Kelley J, Yerra L, et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19(2):91–104.
   PubMed Web of Science ®Google Scholar
• Angelovich T, Hearps A, Jaworowski A. Inflammation-induced foam cell formation in chronic inflammatory disease. Immunol Cell Biol. 2015;93(8):683–693.
   PubMed Web of Science ®Google Scholar
• Ekstrand M, Trajkovska M, Perman-Sundelin J, et al. Imaging of intracellular and extracellular ROS levels in atherosclerotic mouse aortas ex vivo: effects of lipid lowering by diet or atorvastatin. PLoS ONE. 2015;10(6):e0130898. Article ID.
   PubMed Web of Science ®Google Scholar
• Manea A, Manea S, Gan A, et al. Human monocytes and macrophages express NADPH oxidase 5; A potential source of reactive oxygen species in atherosclerosis. Biochem Biophys Res Commun. 2015;461(1):172–179.
   PubMed Web of Science ®Google Scholar
• Hamilton T, Major J, Armstrong D, et al. Oxidized LDL modulates activation of NFkappaB in mononuclear phagocytes by altering the degradation if IkappaBs. J Leukoc Biol. 1998;64(5):667–674.
   PubMed Web of Science ®Google Scholar
• Ares MP, Kallin B, Eriksson P, et al. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor- κB in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15(10):1584–1590.
   PubMed Web of Science ®Google Scholar
• Basu S, Nagy JA, Pal S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001;7(5):569–574.52.
   PubMed Web of Science ®Google Scholar
• Chakroborty D, Sarkar C, Yu H, et al. Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Krüppel-like factor-2 expression in tumor endothelial cells. Proc Natl Acad Sci USA. 2011;108(51):20730–20735.
   PubMed Web of Science ®Google Scholar